GlassScriptPhysician profile
Andrew B Stefaniwsky
NPI 1811061807
$4,271.53
in general payments reported to CMS, 2019-2025
46 companies · $713 in 2025
The $713 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,257 · 2020: $423 · 2021: $406 · 2022: $483 · 2023: $365 · 2024: $624 · 2025: $713.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,702.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,701.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $753.24 | 2019-2025 | Rinvoq, Skyrizi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $628.92 | 2019-2025 | Xifaxan, Trulance |
| Takeda Pharmaceuticals U.S.A., INC. | $413.99 | 2019-2025 | Entyvio, Gattex, Eohilia |
| Celgene Corporation | $296.83 | 2021-2024 | Zeposia |
| Pfizer INC. | $192.55 | 2023-2025 | |
| Novo Nordisk INC | $184.24 | 2019-2025 | Wegovy |
| Merck Sharp & Dohme LLC | $140.69 | 2019-2022 | |
| Janssen Biotech, INC. | $129.14 | 2024-2025 | Tremfya, Stelara |
| Ferring Pharmaceuticals INC. | $129.05 | 2019-2022 | |
| Nestle Healthcare Nutrition INC. | $101.90 | 2021-2023 | |
| Braintree Laboratories, INC. | $94.04 | 2022-2025 | Suflave |
| Kowa Pharmaceuticals America, INC. | $82.49 | 2019-2020 | |
| Aimmune Therapeutics, INC. | $75.77 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $72.66 | 2019-2020 | |
| Abbott Laboratories | $65.23 | 2025 | Freestyle Libre 3 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Stefaniwsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.